1354355-58-0

Basic information

• Product Name: (4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)methanamine
• Synonyms: (4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)methanamine
• CAS NO: 1354355-58-0
• Molecular Weight: 252.239
• Mol File: 1354355-58-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)methanamine(1354355-58-0)
• EPA Substance Registry System: (4-(2-(trifluoromethyl)pyridin-4-yl)phenyl)methanamine(1354355-58-0)

Safety Data

• Hazardous Substances Data: 1354355-58-0(Hazardous Substances Data)

Upstream product

• 590371-73-6 2-(trifluoromethyl)pyridine-4-iodide 
• 850568-55-7 (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine hydrochloride 
• 131748-14-6 4-chloro-2-trifluoromethylpyridine 

Downstream Products

• 1354353-79-9 4-(pyrazin-2-yl)-N-(4-(2-(trifluoromethyl)pyridin-4-yl)benzyl)benzamide 

Relevant articles and documents

NITROGEN-CONTAINING HETEROCYCLIC COMPOUND

Provided is a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, and useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder and the like. The present invention relates to a compound represented by the formula wherein ring A is a 4- to 7-membered ring optionally having substituent (s) ; L is -O-, -S-, -SO- or -SO2-; R1 is a C1-6 alkyl group optionally having substituent(s) (provided that when L is -O-, R1 is not a C1-6 alkyl group optionally substituted by halogen atom(s)), or a cyclic group optionally having substituent(s); X1 is -CRa= or -N=; X2 is -CRb= or -N=; X3 is-CRc= or -N=; Ra, Rb and Rc are each a C1-6 alkyl group, C2-6 alkenyl group, C1-6 alkoxy group, C3-6 cycloalkyl group, C3-6 cycloalkoxy group or C6-14 aryl group, each of which optionally having substituent(s), H or halogen, or a salt thereof.